NCT05034991 The Role of Endometrial Blood Flow in Endometrial Cancer
| NCT ID | NCT05034991 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Far Eastern Memorial Hospital |
| Condition | Endometrial Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2021-01-05 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2021-01-05 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The incidence of endometrial cancer is gradually increasing nowaday. Sonography can be used to evaluate the endometrial volume, the vascularity and the blood flow. This study will analyze the role of preoperative endometrial blood flow in the outcome of endometrial cancer patients.
Eligibility Criteria
Inclusion Criteria: \- \>20 years old female had Endometrial cancer Exclusion Criteria: \- \<20 years old female
Contact & Investigator
Frequently Asked Questions
Who can join the NCT05034991 clinical trial?
This trial is open to female participants only, aged 20 Years or older, studying Endometrial Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05034991 currently recruiting?
Yes, NCT05034991 is actively recruiting participants. Contact the research team at smhsiao2@gmail.com for enrollment information.
Where is the NCT05034991 trial being conducted?
This trial is being conducted at Banqiao District, Taiwan.
Who is sponsoring the NCT05034991 clinical trial?
NCT05034991 is sponsored by Far Eastern Memorial Hospital. The trial plans to enroll 75 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.